Acute cholangitis is diagnosed on the basis of the clinical features, supported by laboratory evidence of systemic infection. Imaging is helpful in revealing biliary obstruction and any underlying ...

Medically reviewed by Jay N. Yepuri, MD PBC is a chronic liver disease that damages bile ducts and can lead to liver failure. You can get treatment for PBC to slow disease progression and manage ...

Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized by the destruction of interlobular bile ducts, leading to cholestasis and liver fibrosis. Whether elafibranor, an ...

PARIS — Statins can significantly reduce the risk for complications and death from primary sclerosing cholangitis, results from a Swedish registry study show. Primary sclerosing cholangitis is ...

Effective treatments for patients with primary biliary cholangitis are limited. Seladelpar, a peroxisome proliferator–activated receptor delta agonist, has potential benefits. In this phase 3, ...

– New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to demonstrate the effectiveness of Livdelzi (seladelpar) in reducing pruritus in ...

The survey of European hepatologists demonstrates the lack of clarity in guidelines. A new survey of European health care centers with expertise in managing primary sclerosing cholangitis (PSC) ...

In vitro sensitivity to 5-FU and gemcitabine in pancreatic cancer. Background: Patients with biliary tract cancer (BTC) have a high risk of developing cholangitis. In patients with advanced BTC ...

Please provide your email address to receive an email when new articles are posted on . In line with an earlier panel decision, FDA denied full approval to Ocaliva for primary biliary cholangitis. FDA ...

At a routine follow-up visit at the clinic a month prior, the patient reported consuming at least 2 bags of unpeeled lemons per day. A recently published report describes the case of a 50-year-old ...